Leading development and innovation in molecular testing
Since 2006, they have been designing and developing products in preparation for the universal influence of a pandemic. More than 15 years of continued investment and research have led them to some of the largest breakthroughs in the testing space. Their unique diagnostic solutions thrive in a wide variety of environments, helping to diagnose and treat infectious diseases such as Influenza, SARS-CoV-2, Monkeypox, and Mycobacterium Tuberculosis (MTB).
The strength and scalability of their products has allowed them to grow into a large, competitive operation in a matter of weeks. Whereas they could previously produce 50-100k tubes of PrimeStore MTM per month, during the COVID-19 pandemic weekly shipments have exceeded two million tubes.